Latent, Lytic, and Linked to Multiple Sclerosis-How EBV Drives Autoimmunity

Area of Science:

• Immunology
• Neuroscience
• Oncology

Background:

• Epstein-Barr virus (EBV) is a human tumor virus linked to lymphomas and carcinomas.
• Epidemiological studies suggest EBV infection is necessary for developing multiple sclerosis (MS).

Purpose of the Study:

• To explore how EBV-driven oncogenes may induce B cell differentiation, leading to neuroinflammation in MS.
• To discuss the role of immune control in the infiltration of T-bet+CXCR3+ B cells into the central nervous system (CNS).

Main Methods:

• Review of existing epidemiological and immunological studies on EBV, B cells, and MS.
• Discussion of potential mechanisms of B cell differentiation and CNS infiltration driven by EBV.

Main Results:

• Insufficient immune control may permit T-bet+CXCR3+ B cells to enter the CNS.
• These B cells can attract other lymphocytes, stimulate T cells, and differentiate into antibody-producing plasma cells.
• This process contributes to neuroinflammation and autoantibody production in a subset of MS patients.

Conclusions:

• EBV-driven B cell populations in the CNS may play a significant role in MS pathogenesis.
• Targeting these CNS-infiltrating B cells with EBV-specific treatments could be a complementary therapeutic strategy for MS.